Renu Bharadwaj

Eli Lilly (United States) — United States

Medicine · Health Sciences

28h-index2.5kcitations167works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(29), Leptospirosis research and findings(17), Bacterial Identification and Susceptibility Testing(16), Viral Infections and Vectors(14), Pneumonia and Respiratory Infections(13)

Publications166 total

A multimodal perspective to overcome translational barriers in cerebrospinal drug delivery
Expert Opinion on Drug Delivery·2025Open Access
Text-to-Braille Conversion System Using Microcontroller and Servo Motors
Lecture notes in networks and systems·2025
Burning Mouth Syndrome-Pathogenesis, Diagnosis, and Multidisciplinary Approach
International Journal of Science and Research (IJSR)·2025Open Access
Pancreas transplant outcomes in patients with human immunodeficiency virus infection
American Journal of Transplantation·2024
Comparative immune responses to Mycobacterium tuberculosis in people with latent infection or sterilizing protection
iScience·2023· 5 citedOpen Access
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
BMC Pregnancy and Childbirth·2023· 2 citedOpen Access
Comparative immune responses to <i>Mycobacterium tuberculosis</i> in people with latent infection or sterilizing protection
2022Open Access
Linezolid-resistant Mycobacterium tuberculosis
The Indian Journal of Medical Research·2021· 2 citedOpen Access
Host lipidome and tuberculosis treatment failure
European Respiratory Journal·2021· 20 citedOpen Access
Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India
Open Forum Infectious Diseases·2021· 37 citedOpen Access
Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes
The International Journal of Tuberculosis and Lung Disease·2021· 13 cited
Resistance pattern among contemporary Gram positive clinical isolates and in vitro activity of novel antibiotic, Levonadifloxacin (WCK 771)
International Journal of Infectious Diseases·2020· 5 citedOpen Access
Resistance pattern among contemporary gram-negative clinical isolates and in vitro activity of novel antibiotic, WCK5222 (cefepime-zidebactam)
International Journal of Infectious Diseases·2020Open Access
Post-infectional changes associated with the progression of leaf spot disease in Calotropis procera Aiton
Physiological and Molecular Plant Pathology·2020· 3 cited
Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India
PLoS ONE·2020· 51 citedOpen Access
Intensified Short Symptom Screening Program for Dengue Infection during Pregnancy, India
Emerging infectious diseases·2020· 5 citedOpen Access
Cryptococcal Antigenemia in HIV-Infected Patients with CD4+ T-cell Count ≤ 200 cells/μl: A study from a tertiary care hospital
International Journal of Contemporary Medical Research [IJCMR]·2020· 1 citedOpen Access
Brucellosis among patients with pyrexia of unknown origin
MedPulse International Journal of Microbiology·2020· 1 citedOpen Access
Assessment of the Xpert assay among adult pulmonary tuberculosis suspects with and without diabetes mellitus
The International Journal of Tuberculosis and Lung Disease·2020· 4 cited
Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-Diabetes
Prostaglandins & Other Lipid Mediators·2019· 26 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Amita Gupta(23), Vidya Mave(20), Nikhil Gupte(19), Anju Kagal(16), Vandana Kulkarni(16), Nishi Suryavanshi(14), Dileep Kadam(10), Neeta Pradhan(9), Aarti Kinikar(8), Robert C. Bollinger(8), Akshay Gupte(8), Ramesh Bhosale(7), Sujata Dharmshale(6), Sandesh Patil(6), Jayagowri Sastry(5), Savita Kanade(5), Rahul Lokhande(5), Jonathan E. Golub(5), Rupak Shivakoti(5), Suvarna Joshi(4)